Home/Filings/4/0001062993-21-004866
4//SEC Filing

Chadha Deepak 4

Accession 0001062993-21-004866

CIK 0000819050other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 5:01 PM ET

Size

6.3 KB

Accession

0001062993-21-004866

Insider Transaction Report

Form 4
Period: 2021-05-18
Chadha Deepak
Chief Research & Dev. Officer
Transactions
  • Purchase

    Common Stock

    2021-05-19$0.83/sh+12,500$10,37878,167 total
  • Purchase

    Common Stock

    2021-05-18$0.82/sh+2,700$2,21265,667 total
Footnotes (1)
  • [F1]Represents the purchase of 12,500 shares in multiple transactions, ranging in price from $0.814 to $0.857 per share, resulting in a weighted average purchase price of $0.8302. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1
  • filerCIK 0001784380

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:01 PM ET
Size
6.3 KB